You are here

Article info

Article menu

Download PDFPDF

XML
Review
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies

Authors

  • Daniela GM Tantalo Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Amanda J Oliver Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  • Bianca von Scheidt Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Aaron J Harrison Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Scott N Mueller Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, AustraliaThe Australian Research Council Centre of Excellence in Advanced Molecular Imaging, The University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Michael H Kershaw Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  • Clare Y Slaney Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles

Citation

Tantalo DG, Oliver AJ, von Scheidt B, et al
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies
Journal for ImmunoTherapy of Cancer 2021;9:e002555. doi: 10.1136/jitc-2021-002555
Online issue publication 
February 07, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.